Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News PvP Biologics launches Phase 1 trials for celiac disease candidate Kuma062 PvP Biologics, a US-based pharmaceutical company, has recently begun two phase 1 clinical trials to assess the safety,… bypharmanewsdailySeptember 8, 2018
